Related Experiment Video
Updated: Dec 23, 2025

20:23
A Lectin HPLC Method to Enrich Selectively-glycosylated Peptides from Complex Biological Samples
Published on: October 1, 2009
16.4K
Recombinant Lectin from Tepary Bean (Phaseolus acutifolius) with Specific Recognition for Cancer-Associated Glycans:
Dania Martínez-Alarcón1,2, Annabelle Varrot2, Elaine Fitches3
1Centro de Investigación y de Estudios Avanzados Unidad Irapuato, Departamento de Biotecnología y Bioquímica, Irapuato 36821, Guanaj uato, Mexico.
Biomolecules
|April 29, 2020
Summary
Recombinant Tepary bean lectin (rTBL-1) was produced and its 3D structure determined. This lectin specifically recognizes cancer-associated N-glycans, distinguishing them from those on healthy cells.
Area of Science:
- Biochemistry
- Structural Biology
- Glycobiology
Background:
- Lectins are proteins that bind carbohydrates and play roles in biological recognition.
- Tepary bean lectins have shown potential in distinguishing between healthy and cancerous cells.
- Understanding lectin structure-function relationships is crucial for developing targeted therapies.
Purpose of the Study:
- To produce and characterize recombinant Tepary bean lectin (rTBL-1).
- To determine the three-dimensional (3D) structure of rTBL-1.
- To investigate the differential recognition of rTBL-1 for cancer-associated glycoconjugates.
Main Methods:
- Recombinant protein expression in Pichia pastoris.
- Nickel affinity chromatography for purification.
- X-ray diffraction for 3D structure determination.
- Glycan array screening and Isothermal Titration Calorimetry (ITC) for binding analysis.
Main Results:
- rTBL-1 was successfully produced (316 mg/L) and purified as a stable 120 kDa homo-tetramer.
- The 3D structure revealed canonical leguminous lectin fold with bound Ca2+ and Mn2+ ions.
- rTBL-1 specifically recognized 14 cancer-associated β1-6 branched N-glycans, with improved binding in the presence of α1-6 core fucose.
- No interaction was observed with mono- and disaccharides, indicating high specificity for larger glycans.
Conclusions:
- The determined 3D structure of rTBL-1 provides insights into its carbohydrate-binding mechanism.
- rTBL-1 exhibits selective binding towards cancer-associated N-glycans.
- This specificity suggests potential applications of rTBL-1 in cancer diagnostics or therapeutics.

